160 related articles for article (PubMed ID: 32538774)
1. TRAIL mediated signaling as a double-edged sword in pancreatic cancer: Analysis of brighter and darker sides of the pathway.
Farooqi AA; Zahid R; Maryam A; Naureen H; Attar R; Sabitaliyevich UY; Konysbayevna KK
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):215-220. PubMed ID: 32538774
[TBL] [Abstract][Full Text] [Related]
2. TRAIL mediated signaling in different cancers: cancer in the "Crosshairs".
Farooqi AA; Naureen H; Yilmaz S; Sabitaliyevich UY; Zhailganov A; Rabandiyarov M; Ucak I; Karasholakova L; Attar R
Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):1-8. PubMed ID: 34174975
[TBL] [Abstract][Full Text] [Related]
3. Natural Product Mediated Regulation of Death Receptors and Intracellular Machinery: Fresh from the Pipeline about TRAIL-Mediated Signaling and Natural TRAIL Sensitizers.
Shahwar D; Iqbal MJ; Nisa MU; Todorovska M; Attar R; Sabitaliyevich UY; Farooqi AA; Ahmad A; Xu B
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022877
[TBL] [Abstract][Full Text] [Related]
4. TRAIL mediated signaling in pancreatic cancer.
Nogueira DR; Yaylim I; Aamir Q; Kahraman OT; Fayyaz S; Kamran-ul-Hassan Naqvi S; Farooqi AA
Asian Pac J Cancer Prev; 2014; 15(15):5977-82. PubMed ID: 25124560
[TBL] [Abstract][Full Text] [Related]
5. TRAIL Mediated Signaling in Breast Cancer: Awakening Guardian Angel to Induce Apoptosis and Overcome Drug Resistance.
Yin N; Yi L; Khalid S; Ozbey U; Sabitaliyevich UY; Farooqi AA
Adv Exp Med Biol; 2019; 1152():243-252. PubMed ID: 31456187
[TBL] [Abstract][Full Text] [Related]
6. New Frontiers in Promoting TRAIL-Mediated Cell Death: Focus on Natural Sensitizers, miRNAs, and Nanotechnological Advancements.
Farooqi AA; Gadaleta CD; Ranieri G; Fayyaz S; Marech I
Cell Biochem Biophys; 2016 Mar; 74(1):3-10. PubMed ID: 26972296
[TBL] [Abstract][Full Text] [Related]
7. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA regulation of TRAIL mediated signaling in different cancers: Control of micro steering wheels during the journey from bench-top to the bedside.
Fayyaz S; Javed Z; Attar R; Farooqi AA; Yaylim I; Ahmad A
Semin Cancer Biol; 2019 Oct; 58():56-64. PubMed ID: 30716480
[TBL] [Abstract][Full Text] [Related]
9. Dealing naturally with stumbling blocks on highways and byways of TRAIL induced signaling.
Rana A; Attar R; Qureshi MZ; Gasparri ML; Donato VD; Ali GM; Farooqi AA
Asian Pac J Cancer Prev; 2014; 15(19):8041-6. PubMed ID: 25338981
[TBL] [Abstract][Full Text] [Related]
10. Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways.
Farooqi AA; Butt G; El-Zahaby SA; Attar R; Sabitaliyevich UY; Jovic JJ; Tang KF; Naureen H; Xu B
Pharmacol Res; 2020 Oct; 160():105188. PubMed ID: 32919041
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.
Büneker CK; Yu R; Deedigan L; Mohr A; Zwacka RM
Cancer Lett; 2012 Mar; 316(2):168-77. PubMed ID: 22104728
[TBL] [Abstract][Full Text] [Related]
12. Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer.
Ozawa F; Friess H; Kleeff J; Xu ZW; Zimmermann A; Sheikh MS; Büchler MW
Cancer Lett; 2001 Feb; 163(1):71-81. PubMed ID: 11163110
[TBL] [Abstract][Full Text] [Related]
13. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
14. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
[TBL] [Abstract][Full Text] [Related]
15. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.
Nahacka Z; Svadlenka J; Peterka M; Ksandrova M; Benesova S; Neuzil J; Andera L
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):522-531. PubMed ID: 29278689
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways.
Lin X; Farooqi AA
Semin Cancer Biol; 2021 Aug; 73():302-309. PubMed ID: 33152487
[TBL] [Abstract][Full Text] [Related]
17. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
Harashima N; Takenaga K; Akimoto M; Harada M
Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
[TBL] [Abstract][Full Text] [Related]
18. Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.
Dao P; Smith N; Scott-Algara D; Garbay C; Herbeuval JP; Chen H
Cancer Lett; 2015 Apr; 360(1):48-59. PubMed ID: 25684663
[TBL] [Abstract][Full Text] [Related]
19. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
[TBL] [Abstract][Full Text] [Related]
20. Restoring TRAIL mediated signaling in ovarian cancer cells.
Farooqi AA; Yaylim I; Ozkan NE; Zaman F; Halim TA; Chang HW
Arch Immunol Ther Exp (Warsz); 2014 Dec; 62(6):459-74. PubMed ID: 25030086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
